{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:10:57Z","timestamp":1763536257540,"version":"3.45.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shannan Science and Technology Plan Project","award":["SNSBJKJJHXM2024023"],"award-info":[{"award-number":["SNSBJKJJHXM2024023"]}]},{"name":"Key project of Natural Science Foundation of Tibet Autonomous Region","award":["XZ202501ZR0140"],"award-info":[{"award-number":["XZ202501ZR0140"]}]},{"name":"Hubei Province Key R & D Program Aid Project to Tibet"},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2025AFB925"],"award-info":[{"award-number":["2025AFB925"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11883-025-01362-3","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:11:17Z","timestamp":1763532677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications"],"prefix":"10.1007","volume":"27","author":[{"given":"Xiangyun","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingdan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"8 Suppl","key":"1362_CR1","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1362_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131.","journal-title":"Signal Transduct Target Ther"},{"issue":"1 Pt 1","key":"1362_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0092-8674(81)90037-4","volume":"26","author":"JD Termine","year":"1981","unstructured":"Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981;26(1 Pt 1):99\u2013105.","journal-title":"Cell"},{"issue":"4","key":"1362_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrendo.2010.18","volume":"6","author":"K Kos","year":"2010","unstructured":"Kos K, Wilding JP. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol. 2010;6(4):225\u201335.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1362_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1177\/002215549904701201","volume":"47","author":"Q Yan","year":"1999","unstructured":"Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochemistry: Official J Histochem Soc. 1999;47(12):1495\u2013506.","journal-title":"J Histochem Cytochemistry: Official J Histochem Soc"},{"issue":"13","key":"1362_CR6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.13.8","volume":"63","author":"J Feldt","year":"2022","unstructured":"Feldt J, Garriz A, Rodriguez Benavente MC, Woodward AM, Zoukhri D, Arg\u00fceso P. The matricellular protein SPARC decreases in the lacrimal gland at adulthood and during inflammation. Invest Ophthalmol Vis Sci. 2022;63(13):8.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1362_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/art.1780390402","volume":"39","author":"S Nakamura","year":"1996","unstructured":"Nakamura S, Kamihagi K, Satakeda H, Katayama M, Pan H, Okamoto H, et al. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Arthritis Rheum. 1996;39(4):539\u201351.","journal-title":"Arthritis Rheum"},{"issue":"20","key":"1362_CR8","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/CIRCULATIONAHA.120.046789","volume":"142","author":"N Xia","year":"2020","unstructured":"Xia N, Lu Y, Gu M, Li N, Liu M, Jiao J, et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction. Circulation. 2020;142(20):1956\u201373.","journal-title":"Circulation"},{"issue":"2","key":"1362_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae018","volume":"6","author":"H Ling","year":"2024","unstructured":"Ling H, Li Y, Peng C, Yang S, Seto E. HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR Cancer. 2024;6(2):zcae018.","journal-title":"NAR Cancer"},{"issue":"6","key":"1362_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","volume":"11","author":"IT Tai","year":"2008","unstructured":"Tai IT, Tang MJ. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat. 2008;11(6):231\u201346.","journal-title":"Drug Resist Updat"},{"key":"1362_CR11","doi-asserted-by":"crossref","unstructured":"Toba H, Takai S. Exploring the roles of SPARC as a proinflammatory factor and its potential as a novel therapeutic target against cardiovascular disease. Am J Physiol Heart Circ Physiol. 2024;327(5):H1174-86.","DOI":"10.1152\/ajpheart.00565.2024"},{"issue":"4","key":"1362_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1073\/pnas.89.4.1281","volume":"89","author":"EW Raines","year":"1992","unstructured":"Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA. 1992;89(4):1281\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1362_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/oby.2001.50","volume":"9","author":"M Takahashi","year":"2001","unstructured":"Takahashi M, Nagaretani H, Funahashi T, Nishizawa H, Maeda N, Kishida K, et al. The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. Obes Res. 2001;9(7):388\u201393.","journal-title":"Obes Res"},{"issue":"3","key":"1362_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213494","volume":"14","author":"GM Karere","year":"2019","unstructured":"Karere GM, Glenn JP, Birnbaum S, Garcia R, VandeBerg JL, Cox LA. Identification of coordinately regulated microRNA-gene networks that differ in baboons discordant for LDL-cholesterol. PLoS One. 2019;14(3):e0213494.","journal-title":"PLoS One"},{"key":"1362_CR15","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA et al. \/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e143.","DOI":"10.1161\/CIR.0000000000000698"},{"issue":"6801","key":"1362_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233\u201341.","journal-title":"Nature"},{"issue":"3","key":"1362_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355.","journal-title":"Cell"},{"issue":"8","key":"1362_CR18","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","volume":"132","author":"C Baaten","year":"2023","unstructured":"Baaten C, Vondenhoff S, Noels H. Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease. Circ Res. 2023;132(8):970\u201392.","journal-title":"Circ Res"},{"issue":"3","key":"1362_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367.","journal-title":"Pharmacol Rev"},{"key":"1362_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094414","author":"H Toba","year":"2025","unstructured":"Toba H, Ikemoto MJ, Kobara M, Jin D, Takai S, Nakata T. Secreted protein acidic and rich in cysteine (SPARC) induced by the renin-angiotensin system causes endothelial inflammation in the early stages of hypertensive vascular injury. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26094414.","journal-title":"Int J Mol Sci"},{"key":"1362_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.matbio.2018.04.015","volume":"74","author":"M Rienks","year":"2018","unstructured":"Rienks M, Carai P, van Teeffelen J, Eskens B, Verhesen W, Hemmeryckx B, et al. SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis. Matrix Biol. 2018;74:21\u201334.","journal-title":"Matrix Biol"},{"issue":"3","key":"1362_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1189\/jlb.1105664","volume":"81","author":"KA Kelly","year":"2007","unstructured":"Kelly KA, Allport JR, Yu AM, Sinh S, Sage EH, Gerszten RE, et al. SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J Leukoc Biol. 2007;81(3):748\u201356.","journal-title":"J Leukoc Biol"},{"key":"1362_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7993","volume":"6","author":"M Tichet","year":"2015","unstructured":"Tichet M, Prod\u2019Homme V, Fenouille N, Ambrosetti D, Mallavialle A, Cerezo M, et al. Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nat Commun. 2015;6:6993.","journal-title":"Nat Commun"},{"issue":"8","key":"1362_CR24","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1073\/pnas.91.8.3448","volume":"91","author":"SE Goldblum","year":"1994","unstructured":"Goldblum SE, Ding X, Funk SE, Sage EH. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA. 1994;91(8):3448\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1362_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0657-9","volume":"13","author":"S Alkabie","year":"2016","unstructured":"Alkabie S, Basivireddy J, Zhou L, Roskams J, Rieckmann P, Quandt JA. SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties. J Neuroinflammation. 2016;13(1):225.","journal-title":"J Neuroinflammation"},{"key":"1362_CR26","doi-asserted-by":"crossref","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):Iii27-32.","DOI":"10.1161\/01.CIR.0000131515.03336.f8"},{"issue":"1","key":"1362_CR27","first-page":"250","volume":"16","author":"R Yan","year":"2024","unstructured":"Yan R, Zhang X, Xu W, Li J, Sun Y, Cui S, et al. ROS-Induced endothelial dysfunction in the pathogenesis of atherosclerosis. Aging Disease. 2024;16(1):250\u201368.","journal-title":"Aging Disease"},{"issue":"1","key":"1362_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03003-8","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yu J, Huang A, Yang Q, Li G, Yang Y, et al. ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC. Cancer Cell Int. 2023;23(1):152.","journal-title":"Cancer Cell Int"},{"key":"1362_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117390","volume":"388","author":"X Li","year":"2024","unstructured":"Li X, Zhao W, Li X, Chen X, Li Y, He J, et al. The association of SPARC with hypertension and its function in endothelial-dependent relaxation. Atherosclerosis. 2024;388:117390.","journal-title":"Atherosclerosis"},{"issue":"12","key":"1362_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, J\u00f8rgensen HF, Clarke MCH, Bennett MR, Mallat Z. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16(12):727\u201344.","journal-title":"Nat Rev Cardiol"},{"key":"1362_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111856","volume":"132","author":"S Hu","year":"2024","unstructured":"Hu S, Zhang X, Ding Y, Liu X, Xia R, Wang X. Inhibition of SPARC signal by aerobic exercise to ameliorate atherosclerosis. Int Immunopharmacol. 2024;132:111856.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1362_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cytogfr.2004.03.004","volume":"15","author":"EW Raines","year":"2004","unstructured":"Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004;15(4):237\u201354.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"1362_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/jcb.10095","volume":"84","author":"K Motamed","year":"2002","unstructured":"Motamed K, Funk SE, Koyama H, Ross R, Raines EW, Sage EH. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J Cell Biochem. 2002;84(4):759\u201371.","journal-title":"J Cell Biochem"},{"issue":"4","key":"1362_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12031-016-0827-3","volume":"60","author":"GF Ye","year":"2016","unstructured":"Ye GF, Zhu SW, Zhu SG, Li F, Wang YY. Secreted protein acidic and rich in cysteine modulates molecular arterial homeostasis of human arterial smooth muscle cells in vitro. J Mol Neurosci. 2016;60(4):509\u201316.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"1362_CR35","first-page":"160","volume":"19","author":"E Farrokhi","year":"2015","unstructured":"Farrokhi E, GhatrehSamani K, Hashemzadeh Chaleshtori M, Tabatabaiefar MA. Effect of oxidized low density lipoprotein on the expression of Runx2 and SPARC genes in vascular smooth muscle cells. Iran Biomed J. 2015;19(3):160\u20134.","journal-title":"Iran Biomed J"},{"issue":"12","key":"1362_CR36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.121.057001","volume":"145","author":"C Veith","year":"2022","unstructured":"Veith C, Vart\u00fcrk-\u00d6zcan I, Wujak M, Hadzic S, Wu CY, Knoepp F, et al. SPARC, a novel regulator of vascular cell function in pulmonary hypertension. Circulation. 2022;145(12):916\u201333.","journal-title":"Circulation"},{"issue":"10","key":"1362_CR37","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630\u201345.","journal-title":"Cell"},{"issue":"11","key":"1362_CR38","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s12031-020-01566-z","volume":"70","author":"X Tan","year":"2020","unstructured":"Tan X, Li T, Zhu S, Zhong W, Li F, Wang Y. Induction of SPARC on oxidative stress, inflammatory phenotype transformation, and apoptosis of human brain smooth muscle cells via TGF-\u03b21-NOX4 pathway. J Mol Neurosci. 2020;70(11):1728\u201341.","journal-title":"J Mol Neurosci"},{"key":"1362_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134485","volume":"712","author":"T Li","year":"2019","unstructured":"Li T, Tan X, Zhu S, Zhong W, Huang B, Sun J, et al. SPARC induces phenotypic modulation of human brain vascular smooth muscle cells via AMPK\/mTOR-mediated autophagy. Neurosci Lett. 2019;712:134485.","journal-title":"Neurosci Lett"},{"issue":"4","key":"1362_CR40","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692\u2013702.","journal-title":"Circ Res"},{"issue":"2","key":"1362_CR41","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1161\/ATVBAHA.120.313584","volume":"41","author":"MK Khoury","year":"2021","unstructured":"Khoury MK, Yang H, Liu B. Macrophage biology in cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2021;41(2):e77\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1362_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MOL.0b013e32834a97e4","volume":"22","author":"S Adamson","year":"2011","unstructured":"Adamson S, Leitinger N. Phenotypic modulation of macrophages in response to plaque lipids. Curr Opin Lipidol. 2011;22(5):335\u201342.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"1362_CR43","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.apsb.2020.12.014","volume":"11","author":"Q Hu","year":"2021","unstructured":"Hu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses. Acta Pharm Sin B. 2021;11(6):1493\u2013512.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"1362_CR44","doi-asserted-by":"publisher","first-page":"C972","DOI":"10.1152\/ajpcell.00402.2014","volume":"308","author":"H Toba","year":"2015","unstructured":"Toba H, de Castro Br\u00e1s LE, Baicu CF, Zile MR, Lindsey ML, Bradshaw AD. Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization. Am J Physiol Cell Physiol. 2015;308(12):C972\u201382.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"1362_CR45","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.immuni.2022.07.007","volume":"55","author":"S Ryu","year":"2022","unstructured":"Ryu S, Sidorov S, Ravussin E, Artyomov M, Iwasaki A, Wang A, et al. The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging. Immunity. 2022;55(9):1609\u2013e267.","journal-title":"Immunity"},{"key":"1362_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169173","author":"S Ryu","year":"2023","unstructured":"Ryu S, Spadaro O, Sidorov S, Lee AH, Caprio S, Morrison C, et al. Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI169173.","journal-title":"J Clin Invest"},{"issue":"8","key":"1362_CR47","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/febs.17058","volume":"291","author":"G Xiao","year":"2024","unstructured":"Xiao G, Wei Y, Xie R, Tsang Y, Gu J, Shen D, et al. Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet. FEBS J. 2024;291(8):1699\u2013718.","journal-title":"FEBS J"},{"issue":"3","key":"1362_CR48","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4103\/1673-5374.350210","volume":"18","author":"ZY Li","year":"2023","unstructured":"Li ZY, Zhou AF, Li G, Zhou LY, Pu PM, Zhu K, et al. Chronic spinal cord compression associated with intervertebral disc degeneration in SPARC-null mice. Neural Regen Res. 2023;18(3):634\u201342.","journal-title":"Neural Regen Res"},{"issue":"5","key":"1362_CR49","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4149\/neo_2022_220324N333","volume":"69","author":"SK Deng","year":"2022","unstructured":"Deng SK, Jin Y, Jin Y, Wang JF. SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells. Neoplasma. 2022;69(5):1101\u20137.","journal-title":"Neoplasma"},{"issue":"7","key":"1362_CR50","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1161\/ATVBAHA.112.249847","volume":"32","author":"Y Ding","year":"2012","unstructured":"Ding Y, Subramanian S, Montes VN, Goodspeed L, Wang S, Han C, et al. Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2012;32(7):1596\u2013604.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1362_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48589-3","volume":"15","author":"G Zhao","year":"2024","unstructured":"Zhao G, Gentile ME, Xue L, Cosgriff CV, Weiner AI, Adams-Tzivelekidis S, et al. Vascular endothelial-derived SPARCL1 exacerbates viral pneumonia through pro-inflammatory macrophage activation. Nat Commun. 2024;15(1):4235.","journal-title":"Nat Commun"},{"key":"1362_CR52","first-page":"183","volume":"1344","author":"T Sekiya","year":"2016","unstructured":"Sekiya T, Yoshimura A. Vitro Th differentiation Protocol. Methods in molecular biology. (Clifton NJ). 2016;1344:183\u201391.","journal-title":"(Clifton NJ)"},{"issue":"4","key":"1362_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaut.2011.09.002","volume":"37","author":"S Piconese","year":"2011","unstructured":"Piconese S, Costanza M, Tripodo C, Sangaletti S, Musio S, Pittoni P, et al. The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses. J Autoimmun. 2011;37(4):300\u201310.","journal-title":"J Autoimmun"},{"issue":"3","key":"1362_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/jgh.13842","volume":"33","author":"M Tanaka","year":"2018","unstructured":"Tanaka M, Takagi T, Naito Y, Uchiyama K, Hotta Y, Toyokawa Y, et al. Secreted protein acidic and rich in cysteine functions in colitis via IL17A regulation in mucosal CD4(+) T cells. J Gastroenterol Hepatol. 2018;33(3):671\u201380.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1362_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","volume":"106","author":"C Erbel","year":"2011","unstructured":"Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol. 2011;106(1):125\u201334.","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"1362_CR56","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr., Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Reviews Cardiol. 2019;16(7):389\u2013406.","journal-title":"Nat Reviews Cardiol"},{"issue":"11","key":"1362_CR57","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1182\/blood.2020005407","volume":"137","author":"F Shahneh","year":"2021","unstructured":"Shahneh F, Grill A, Klein M, Frauhammer F, Bopp T, Sch\u00e4fer K, et al. Specialized regulatory T cells control venous blood clot resolution through SPARC. Blood. 2021;137(11):1517\u201326.","journal-title":"Blood"},{"key":"1362_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2014.11.007","volume":"147","author":"S Ye","year":"2015","unstructured":"Ye S. Putative targeting of matrix metalloproteinase-8 in atherosclerosis. Pharmacol Ther. 2015;147:111\u201322.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1362_CR59","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cvr\/cvw114","volume":"111","author":"AC Foks","year":"2016","unstructured":"Foks AC, Van Puijvelde GH, Wolbert J, Kr\u00f6ner MJ, Frodermann V, Van Der Heijden T, et al. CD11b\u2009+\u2009Gr-1\u2009+\u2009myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. Cardiovascular Res. 2016;111(3):252\u201361.","journal-title":"Cardiovascular Res"},{"issue":"1","key":"1362_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.celrep.2016.08.075","volume":"17","author":"S Sangaletti","year":"2016","unstructured":"Sangaletti S, Tripodo C, Santangelo A, Castioni N, Portararo P, Gulino A, et al. Mesenchymal transition of high-grade breast carcinomas depends on extracellular matrix control of myeloid suppressor cell activity. Cell Rep. 2016;17(1):233\u201348.","journal-title":"Cell Rep"},{"key":"1362_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01369","volume":"10","author":"S Sangaletti","year":"2019","unstructured":"Sangaletti S, Talarico G, Chiodoni C, Cappetti B, Botti L, Portararo P, et al. SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities. Front Immunol. 2019;10:1369.","journal-title":"Front Immunol"},{"issue":"34","key":"1362_CR62","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1038\/s41388-022-02401-y","volume":"41","author":"M Bellenghi","year":"2022","unstructured":"Bellenghi M, Talarico G, Botti L, Puglisi R, Tabolacci C, Portararo P, et al. SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model. Oncogene. 2022;41(34):4055\u201365.","journal-title":"Oncogene"},{"issue":"18","key":"1362_CR63","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1039\/D4TB02622E","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Wang L, Xiao K, He Q. Efficient red-emitting carbon dots and albumin composites for precise synovial bioimaging in rheumatoid arthritis. J Mater Chem B. 2025;13(18):5327\u201333.","journal-title":"J Mater Chem B"},{"issue":"6","key":"1362_CR64","first-page":"844","volume":"3","author":"G Rakipovski","year":"2018","unstructured":"Rakipovski G, Rolin B, N\u00f8hr J, Klewe I, Frederiksen KS, Augustin R, et al. The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-\/-) and LDLr(-\/-) mice by a mechanism that includes inflammatory pathways. JACC: Basic to Translational Science. 2018;3(6):844\u201357.","journal-title":"JACC: Basic to Translational Science"},{"key":"1362_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.995007","volume":"13","author":"L Yue","year":"2022","unstructured":"Yue L, Chen S, Ren Q, Niu S, Pan X, Chen X, et al. Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice. Front Endocrinol. 2022;13:995007.","journal-title":"Front Endocrinol"},{"issue":"10278","key":"1362_CR66","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2\u00b74\u00a0mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971\u201384.","journal-title":"Lancet"},{"key":"1362_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01442-1","author":"P Wang","year":"2025","unstructured":"Wang P, Yang JQ, Xu DD, Zhang SJ, Lu S, Ji Y. Madecassoside mitigates acute myocardial infarction injury by activating the PKCB\/SPARC signaling pathway. Acta Pharmacol Sin. 2025. https:\/\/doi.org\/10.1038\/s41401-024-01442-1.","journal-title":"Acta Pharmacol Sin"},{"key":"1362_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108685","volume":"261","author":"A Ugusman","year":"2024","unstructured":"Ugusman A, Hisam NSN, Othman NS, Anuar NNM, Hamid AA, Kumar J, et al. Pharmacological interventions for intraplaque neovascularization in atherosclerosis. Pharmacol Ther. 2024;261:108685.","journal-title":"Pharmacol Ther"},{"key":"1362_CR69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2018.12.020","volume":"281","author":"JE Nahon","year":"2019","unstructured":"Nahon JE, Hoekstra M, van Hulst S, Manta C, Goerdt S, Geerling JJ, et al. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice. Atherosclerosis. 2019;281:47\u201355.","journal-title":"Atherosclerosis"},{"issue":"23","key":"1362_CR70","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.121.058615","volume":"146","author":"CP Manta","year":"2022","unstructured":"Manta CP, Leibing T, Friedrich M, Nolte H, Adrian M, Schledzewski K, et al. Targeting of scavenger receptors Stabilin-1 and Stabilin-2 ameliorates atherosclerosis by a plasma proteome switch mediating monocyte\/macrophage suppression. Circulation. 2022;146(23):1783\u201399.","journal-title":"Circulation"},{"issue":"11","key":"1362_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409419","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, He Y, Zhu X, Zhu J, Deng Z, Zhang H, et al. Elevated SPARC disrupts the intestinal barrier integrity in Crohn\u2019s disease by interacting with OTUD4 and activating the MYD88\/NF-\u03baB pathway. Adv Sci. 2025;12(11):e2409419.","journal-title":"Adv Sci"},{"key":"1362_CR72","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jconrel.2023.12.057","volume":"366","author":"B Zheng","year":"2024","unstructured":"Zheng B, Chen Y, Niu L, Zhang X, Yang Y, Wang S, et al. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy. Journal of controlled release: official journal of the Controlled Release Society. 2024;366:596\u2013610.","journal-title":"Journal of controlled release: official journal of the Controlled Release Society."}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01362-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:03:26Z","timestamp":1763535806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01362-3","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"type":"print","value":"1523-3804"},{"type":"electronic","value":"1534-6242"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}